首页> 外文期刊>Medical Plastics News >BREAKING THE MOULD: A New Generation of Orthopaedic Implants through OsteoFab Technology
【24h】

BREAKING THE MOULD: A New Generation of Orthopaedic Implants through OsteoFab Technology

机译:打破传统:通过OsteoFab技术的新一代骨科植入物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Oxford Performance Materials (OPM) was founded with a specific purpose: to exploit the molecule PolyEtherKetoneKetone (PEKK), a high-performance thermoplastic polymer in the family of PolyArylEtherKetones (PAEKs). OPM's founding mission focuses on the development of PEKK products for use in a wide array of biomedical applications, including extruded products in rod and pellet form, injection moulded parts, and most recently 3D printed implants. In addition to supplying raw material for biomedical applications, OPM produces finished parts for the industrial and medical markets as both an established contract manufacturer and a medical device OEM. OPM is a leader in the development of additively manufactured medical devices and was the first company to receive US FDA clearance for a 3D printed patient specific polymeric implant.
机译:牛津高性能材料(OPM)的成立有一个特定的目的:开发分子PolyEtherKetoneKetone(PEKK),这是PolyArylEtherKetones(PAEK)系列中的高性能热塑性聚合物。 OPM的创立任务专注于开发可用于多种生物医学应用的PEKK产品,包括棒状和颗粒状的挤出产品,注塑件以及最新的3D打印植入物。除了提供生物医学应用的原材料外,OPM还为既定的合同制造商和医疗设备OEM厂商提供工业和医疗市场的成品零件。 OPM是增材制造医疗设备开发的领导者,并且是第一家获得美国FDA批准的3D打印的患者专用聚合物植入物的公司。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号